Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.84K Buy
23
+19
+475% +$2.04K ﹤0.01% 1819
2026
Q1
$410 Hold
4
﹤0.01% 2491
2025
Q4
$402 Hold
4
﹤0.01% 2276
2025
Q3
$346 Buy
4
+2
+100% +$158 ﹤0.01% 2284
2025
Q2
$153 Buy
+2
New +$146 ﹤0.01% 2005

Other funds holding NUVL

Essential Partners's NUVL Position: Q2 2026 in Review

Essential Partners increased its Nuvalent (NUVL) stake by 475% in Q2 2026, buying an estimated $2.04K and bringing the position to 23 shares worth $2.84K. The position accounts for ﹤0.01% of the portfolio, ranked #1819.

Essential Partners first reported a position in NUVL in Q2 2025 and has held it in 5 quarters since. 293 funds tracked by Wall St. Rank hold NUVL as of Q2 2026.

  • Essential Partners held 23 shares of Nuvalent worth $2.84K as of Q2 2026.
  • Essential Partners bought 19 Nuvalent shares in Q2 2026, an estimated $2.04K.
  • Nuvalent made up ﹤0.01% of Essential Partners's portfolio in Q2 2026, its #1819 holding.
  • Essential Partners first reported a position in Nuvalent in Q2 2025 and has held it in 5 quarters since.
  • 293 funds tracked by Wall St. Rank held Nuvalent as of Q2 2026.

Based on Essential Partners's 13F filing for Q2 2026, filed 10 Aug 2026.